{"id":"W4221062043","doi":"10.1158/1538-7445.sabcs21-gs2-07","title":"Abstract GS2-07: Updated results from a phase 3 randomized clinical trial in participants (pts) with 1-3 positive lymph nodes (LN), hormone receptor-positive (HR+) and HER2-negative (HER2-) breast cancer (BC) with recurrence score (RS) ≤ 25 randomized to endocrine therapy (ET) +/- chemotherapy (CT): SWOG S1007 (RxPONDER)","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"Juravinski Cancer Centre; BC Cancer Agency","funders":"","keywords":"Taxane; Medicine; Post-hoc analysis; Internal medicine; Oncology; Breast cancer; Clinical trial; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007688965,0.002233286,0.002821809,0.0006948254,0.0004951362,0.00179751,0.00144228,0.001870833,0.0185376],"category_scores_gemma":[0.007134844,0.0005647255,0.00377785,0.001008221,0.000988676,0.001612603,0.0008556361,0.003282999,0.002084766],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008951609,"about_ca_system_score_gemma":0.00270114,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00139988,"about_ca_topic_score_gemma":0.005740729,"domain_scores_codex":[0.9970188,0.002085386,0.0001731671,0.0002425272,0.000244207,0.0002359021],"domain_scores_gemma":[0.9967204,0.001087775,0.0008049505,0.0004020182,0.0003376437,0.0006471852],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9124799,0.00425237,0.002499647,0.003313703,0.008104312,0.0001256958,0.0001553284,0.0009045239,0.004298851,0.0006423857,0.02307329,0.04014999],"study_design_scores_gemma":[0.9387017,0.04308917,0.00573334,0.0001793158,0.004380429,0.00008418495,0.00005478677,0.0002585895,0.0005264353,0.0005872244,0.006363523,0.0000413527],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8167595,0.02532191,0.005341179,0.009720908,0.003789738,0.0317657,0.08455019,0.001951062,0.02079983],"genre_scores_gemma":[0.8664454,0.008524941,0.009354088,0.0145038,0.00202934,0.02708233,0.05448484,0.0005182484,0.01705707],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0185376,"threshold_uncertainty_score":0.06201446,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08411709192082865,"score_gpt":0.4428197893327876,"score_spread":0.358702697411959,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}